Newsletter

Chronic Inflammatory Demyelinating Polyneuropathy Market
One of the treatable but rare disorders, CIDP is a result of inflammation in peripheral nerves
Chronic Inflammatory Demyelinating Polyneuropathy Market

More Whitepapers / Newsletters

Hereditary ATTR (HATTR) Amyloidosis
Hereditary ATTR (HATTR) Amyloi...

Transthyretin Amyloidosis (ATTR) is a progressive build-up of abnormal deposits of amyloid protein in the body's organs and tissues. Hereditary ATTR (hATTR) amyloidosis is the most common form of ATTR...

Fibrodysplasia Ossificans Progressiva Newsletter
Fibrodysplasia Ossificans Prog...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective tissues and muscle tissues, such as ligaments and tendons. They are replaced by bo...

Microneedles Whitepaper
Microneedles: A Smart and Pain...

A formal medical disorder affecting approximately 10 percent of the world population is trypanophobia, or the fear of needles. Nonetheless, transcutaneous or transdermal injections and intravenous inj...

Methicillin-Resistant Staphylococcus Aureus Market
Methicillin-Resistant Staphylo...

Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by bacteria that have become resistant to antibiotics which would generally be helpful in treating other staph infections. About...

Real-World Evidence & Diagnostics In Cancer: Filling The Gaps In Oncology Treatment
Real-World Evidence & Diagnost...

Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access systems for patients and help clinical decision-making in conditions such as cancer characterized by heter...